Follicular dendritic cells (FDCs) are non-haematopoietic cells that are of stromal origin. They are integrated into the continuous stromal network within lymphoid organs. FDCs can acquire antigen ...

滤泡树突状细胞肉瘤（FDCS）诊断困难。研究人员开展了扁桃体 FDCS 病例研究，对 1 例 55 岁女性进行诊疗，术后放疗，随访 6 个月无异常。该研究强调 FDCS 诊断要点，为相关疾病诊疗提供参考。 滤泡树突状细胞（FDC）是 B 细胞滤泡中来源于间充质的树突状细胞 ...

The alternative text for this image may have been generated using AI. Follicular dendritic cells (FDCs) trap immune complexes to engage B cells that are trafficking through lymphoid follicles, ...

The Drugs Technical Advisory Board (DTAB) has agreed with a report from its sub-committee headed by Dr Nilima Kshirsagar, which declared 16 fixed dose combinations (FDCs) as irrational and recommended ...

New Delhi: Lauding the government's decision to ban 328 fixed-dose combination (FDC) of drugs and restricting another six, a group of NGOs Thursday said it was a step towards rectifying the "grave" ...

The CDSCO order, dated 11 Jan, read that in ’23, the Central Licencing Authority had banned 14 FDCs out of a list of 19 drug cocktails.(Mint) New Delhi: The Central Drugs Standard Control Organization ...

With three more fixed dose combination (FDC) drugs being declared rational, taking the number of FDCs declared rational to 86 under 294 FDCs category, the Drugs Controller General of India (DCGI) has ...

According to a study published in the Journal of Pharmaceutical Policy and Practice in August, the proportion of overall psychotropic FDC sales accounted for by unapproved formulations has fluctuated ...

The Drugs Controller General of India (DCGI) has directed manufacturers to follow a procedure for regularisation of 31 Fixed Dose Combinations (FDCs) declared as rational out of the 294 FDCs as per ...

Banning of odd-344 fixed dose combination (FDCs) drugs may show India in poor light, the commerce ministry has told the Drug Controller General of India (DCGI). FDCs combine two or more combinations ...

The national drugs regulator has issued a directive to state licensing authorities asking them to treat fixed dose combinations (FDCs) strictly as new drugs and not approve them without evaluating ...